PARP-1: A new player in the asthma field?

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue 7, 2011, Pages 811-814

  Szabo E ^a   Kovacs I ^a   Grune, T ^b   Haczku, A ^c   Virag L ^a,d  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOBENZAMIDE; CALPAIN; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; JANUS KINASE 1; JANUS KINASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; STAT6 PROTEIN; TRANSCRIPTION FACTOR GATA 3;

ASTHMA; DNA REPAIR; EDITORIAL; ENZYME ACTIVITY; EOSINOPHIL; HUMAN; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TH2 CELL; UBIQUITINATION;

ALLERGENS; ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-5; MICE; POLY(ADP-RIBOSE) POLYMERASES; RESPIRATORY HYPERSENSITIVITY; STAT6 TRANSCRIPTION FACTOR;

EID: 79957538000     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2011.02551.x     Document Type: Editorial

References (20)

1. Barnes PJ,. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 2008; 118: 3546-3556.
2. Datta R, Naura AS, Zerfaoui M, Oumouna M, Kim H, Ju J, et al., PARP-1 deficiency blocks allergen-induced IL-5 expression by promoting a calpain-dependent degradation of STAT-6. Allergy 2011; in press.
3. Hassa PO, Hottiger MO,. The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front Biosci 2008; 13: 3046-3082. (Pubitemid 351589219)
4. Virag L, Szabo C,. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 2002; 54: 375-429.
5. Havranek T, Aujla PK, Nickola TJ, Rose MC, Scavo LM,. Increased poly(ADP-ribose) polymerase (PARP)-1 expression and activity are associated with inflammation but not goblet cell metaplasia in murine models of allergen-induced airway inflammation. Exp Lung Res 2010; 36: 381-389.
6. Boulares AH, Zoltoski AJ, Sherif ZA, Jolly P, Massaro D, Smulson ME,. Gene knockout or pharmacological inhibition of poly(ADP-ribose) polymerase-1 prevents lung inflammation in a murine model of asthma. Am J Respir Cell Mol Biol 2003; 28: 322-329. (Pubitemid 36238009)
7. Virag L, Bai P, Bak I, Pacher P, Mabley JG, Liaudet L, et al., Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma. Med Sci Monit 2004; 10: BR77-BR83. (Pubitemid 38339027)
8. Suzuki Y, Masini E, Mazzocca C, Cuzzocrea S, Ciampa A, Suzuki H, et al., Inhibition of Poly(ADP-Ribose) Polymerase Prevents Allergen-Induced Asthma-Like Reaction in Sensitized Guinea Pigs. J Pharmacol Exp Ther 2004; 311: 1241-1248. (Pubitemid 39612733)
9. Naura AS, Hans CP, Zerfaoui M, You D, Cormier SA, Oumouna M, et al., Post-allergen challenge inhibition of poly(ADP-ribose) polymerase harbors therapeutic potential for treatment of allergic airway inflammation. Clin Exp Allergy 2008; 38: 839-846. (Pubitemid 351550665)
10. Oliver FJ, Menissier-De MJ, Nacci C, Decker P, Andriantsitohaina R, Muller S, et al., Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 1999; 18: 4446-4454. (Pubitemid 29391254)
11. Hassa PO, Covic M, Hasan S, Imhof R, Hottiger MO,. The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function. J Biol Chem 2001; 276: 45588-45597.
12. Andreone TL, O'Connor M, Denenberg A, Hake PW, Zingarelli B,. Poly(ADP-ribose) polymerase-1 regulates activation of activator protein-1 in murine fibroblasts. J Immunol 2003; 170: 2113-2120. (Pubitemid 36197434)
13. Valdor R, Schreiber V, Saenz L, Martinez T, Munoz-Suano A, Dominguez-Villar M, et al., Regulation of NFAT by poly(ADP-ribose) polymerase activity in T cells. Mol Immunol 2008; 45: 1863-1871.
14. Olabisi OA, Soto-Nieves N, Nieves E, Yang TT, Yang X, Yu RY, et al., Regulation of transcription factor NFAT by ADP-ribosylation. Mol Cell Biol 2008; 28: 2860-2871. (Pubitemid 351556520)
15. Marcilhac A, Raynaud F, Clerc I, Benyamin Y,. Detection and localization of calpain 3-like protease in a neuronal cell line: possible regulation of apoptotic cell death through degradation of nuclear IkappaBalpha. Int J Biochem Cell Biol 2006; 38: 2128-2140. (Pubitemid 44397620)
16. Jung T, Catalgol B, Grune T,. The proteasomal system. Mol Aspects Med 2009; 30: 191-296.
17. Ullrich O, Reinheckel T, Sitte N, Hass R, Grune T, Davies KJ,. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc Natl Acad Sci USA 1999; 96: 6223-6228. (Pubitemid 29256647)
18. Catalgol B, Wendt B, Grimm S, Breusing N, Ozer NK, Grune T,. Chromatin repair after oxidative stress: role of PARP-mediated proteasome activation. Free Radic Biol Med 2010; 48: 673-680.
19. Martinez-Romero R, Martinez-Lara E, Aguilar-Quesada R, Peralta A, Oliver FJ, Siles E,. PARP-1 modulates deferoxamine-induced HIF-1alpha accumulation through the regulation of nitric oxide and oxidative stress. J Cell Biochem 2008; 104: 2248-2260.
20. Won J, Chung SY, Kim SB, Byun BH, Yoon YS, Joe CO,. Dose-dependent UV stabilization of p53 in cultured human cells undergoing apoptosis is mediated by poly(ADP-ribosyl)ation. Mol Cells 2006; 21: 218-223.